| Product name: |
Prevexxion RN+HVT+IBD |
| Active substance: |
Marek's disease virus, strain RN1250, Live, Turkey herpesvirus, strain vHVT013-69 (cell-associated), expressing VP2 protein gene of Infectious bursal disease virus (strain Faragher 52/70), Live |
| Target tribe: |
kur domácí |
| Drug form: |
Koncentrát a rozpouštědlo pro injekční suspenzi |
| Registration date: |
20. 7. 2020 |
| Registration number: |
EU/2/20/255 |
| Verdict holder: |
Boehringer Ingelheim Vetmedica, GmbH
Binger Strasse 173
Ingelheim am Rhein 55216
Phone: , Fax:
Email: |
| ATC vet. code: |
QI01AD - Avian infectious bursal disease virus vaccine (Gumboro disease) + Avian herpes virus vaccine (Marek’s disease) |
| Pharmacotherapeutic group: |
Live viral vaccines |
| Narcotics: |
NO |
| Indication restriction: |
NO |
| Withdrawal period: |
kur domácí
maso: 0 d.
maso: 0 d.
vejce: 0 d.
vejce: 0 d.
|
| Procedure type: |
Centralised |
Table of active package codes| Package code | Size | Package type | Material | Identification code | EU number | Issue |
|---|
| 9908767 | 5 x 1000 dávka | lahvička | sklo | - | - | Na předpis | | 9908768 | 5 x 2000 dávka | lahvička | sklo | - | - | Na předpis | | 9908769 | 4 x 4000 dávka | lahvička | sklo | - | - | Na předpis |
| Package code | Size | Package type | Material | Identification code | EU number | Issue |
|---|
|
Authorisation & Approval 
